Member of Lyonbiopole
Research and development in Biotechnology.
A preclinical stage Biotech company developing the next generation of oncology treatments that will be boost immune system to treat incurable cancers.
Our mission is to take Immunotherapy to the next level of efficiency by stimulating patients immune response and turning hidden cold tumors into hot targets for our immune system.
Strategic application domain: Human Medicine
Application market: Oncology
Type of activity: Therapeutics, Pharma or Biotech
Technologies: Immunotherapy
Created on july 10th, 2018 - 5 employees
Address
63 rue André Bollier 69307 Lyon
Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.
